GloboZymes strongly believes that the future of the company depends on continuous innovation. With that in mind, GloboZymes maintains an active research program directed at defining the molecular mechanisms regulating signal transduction pathways, and their deregulation in cancer and other diseases. One major focus of this research program is to determine the mechanisms regulating the growth suppressor functions of protein serine/threonine phosphatase 2A (PP2A₁, PP2A₂) and how this major multifunctional protein phosphatase may be dysfunctional in cancer. A second effort is concerned with the molecular mechanisms regulating the proto-oncogene c-Jun and AP-1-directed transcriptional processes.

GloboZymes is also developing its research collaboration efforts. Interested researchers are encouraged to contact us with their proposals at info@globozymes.com or by phone at 760-579-0393.